Capricor Therapeutics, Inc. · NASDAQ:CAPR
Montanova Capital, LLC reported a 6.60% stake in Capricor Therapeutics, Inc. (Schedule 13G)
Event Feb 19, 2026 · Filed Feb 26, 2026
Montanova Capital, LLC reported a 6.60% stake in Capricor Therapeutics, Inc., 3,417,891 shares, as a passive investor on Feb 19, 2026. Filed Feb 26, 2026 (Schedule 13G).
- Stake
- 6.60%
- Shares
- 3,417,891
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.60% | 3,417,891 |
| Averill Master Fund, Ltd. | 5.60% | 2,917,420 |
| Aaron Cowen | 6.60% | 3,417,891 |
Source
Related
- Capricor Therapeutics, Inc.
- Montanova Capital, LLC
- Capricor Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026